KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
118 hedge funds and large institutions have $439M invested in Keryx Biopharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 47 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
-12
Holders Change %
-9.23%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
26
Reduced
47
Closed
26
Calls
$5.35M
Puts
$4.62M
Net Calls
+$731K
Net Calls Change
+$864K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.52M |
| 2 |
Millennium Management
New York
|
+$4.38M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.73M |
| 4 |
Goldman Sachs
New York
|
+$2.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$881K |
